Features of BAFF and APRIL receptors on circulating B cells in antineutrophil cytoplasmic antibody-associated vasculitis

被引:4
|
作者
Shimojima, Yasuhiro [1 ]
Kishida, Dai [1 ]
Ichikawa, Takanori [1 ]
Takamatsu, Ryota [1 ]
Nomura, Shun [1 ]
Sekijima, Yoshiki [1 ]
机构
[1] Shinshu Univ, Sch Med, Dept Med Neurol & Rheumatol, Matsumoto, Japan
来源
CLINICAL AND EXPERIMENTAL IMMUNOLOGY | 2023年 / 213卷 / 01期
基金
日本学术振兴会;
关键词
ANCA-associated vasculitis; BAFF; APRIL; BAFF-R; TACI; B-cell subsets; PRIMARY SJOGRENS-SYNDROME; ACTIVATING FACTOR; SERUM-LEVELS; BLYS; BIOLOGY; LYMPHOCYTE; DEFICIENCY; TREG; TACI;
D O I
10.1093/cei/uxad024
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To investigate the features of circulating B cells, their expressing receptors, serum levels of B-cell activation factor of the TNF family (BAFF), and a proliferation-inducing ligand (APRIL) in antineutrophil cytoplasmic antibody-associated vasculitis (AAV). Blood samples from 24 patients with active AAV (a-AAV), 13 with inactive AAV (i-AAV), and 19 healthy controls (HC) were included in this study. The proportion of B cells and their expressing BAFF receptor (BAFF-R), transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI), and B-cell maturation antigen were analyzed via flow cytometry. Serum levels of BAFF, APRIL, and interleukin (IL)-4, IL-6, IL-10, and IL-13 were also evaluated using an enzyme-linked immunosorbent assay. The proportion of plasmablasts (PB)/plasma cells (PC) and serum levels of BAFF, APRIL, IL-4, and IL-6 were significantly higher in a-AAV than in HC. Higher serum levels of BAFF, APRIL, and IL-4 were observed in i-AAV than in HC. Lower expression of BAFF-R on memory B cells and higher expression of TACI on CD19+ cells, immature B cells, and PB/PC were demonstrated in a-AAV and i-AAV than in HC. The population of memory B cells was positively associated with serum APRIL levels and BAFF-R expression in a-AAV. In conclusion, decreased expression of BAFF-R on memory B cells and increased expression of TACI on CD19+ cells, immature B cells, and PB/PC, as well as increased serum levels of BAFF and APRIL, were sustained even in the remission phase of AAV. Persistent aberrant signaling of BAFF/APRIL may contribute to disease relapse. Significantly decreased BAFF-R or increased TACI expression on B-cell subsets were observed in ANCA-associated vasculitis (AAV). Increased serum levels of BAFF and APRIL remained even in AAV remission. APRIL and BAFF-R were positively associated with memory B cell expression in active AAV.
引用
收藏
页码:125 / 137
页数:13
相关论文
共 50 条
  • [31] Preventing Relapses in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
    Arnaud, Laurent
    Zahr, Noel
    Amoura, Zahir
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (10): : 996 - 996
  • [32] Severe Infection in Antineutrophil Cytoplasmic Antibody-associated Vasculitis
    Mohammad, Aladdin J.
    Segelmark, Marten
    Smith, Rona
    Englund, Martin
    Nilsson, Jan-Ake
    Westman, Kerstin
    Merkel, Peter A.
    Jayne, David R. W.
    JOURNAL OF RHEUMATOLOGY, 2017, 44 (10) : 1468 - 1475
  • [33] Clinical features of Korean elderly patients with antineutrophil cytoplasmic antibody-associated vasculitis
    Yoo, Byung-Woo
    Song, Jason Jungsik
    Park, Yong-Beom
    Lee, Sang-Won
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2021, 36 (03): : 731 - +
  • [34] SURVIVAL ANALYSIS IN ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS
    Petelytska, L.
    Iaremenko, O.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 571 - 572
  • [35] Pantoprazole and perinuclear antineutrophil cytoplasmic antibody-associated vasculitis
    Jacobs-Kosmin, D
    Derk, CT
    Sandorfi, N
    JOURNAL OF RHEUMATOLOGY, 2006, 33 (03) : 629 - 632
  • [36] Renal transplantation in antineutrophil cytoplasmic antibody-associated vasculitis
    Moran, Sarah
    Little, Mark A.
    CURRENT OPINION IN RHEUMATOLOGY, 2014, 26 (01) : 37 - 41
  • [37] Treatment of antineutrophil cytoplasmic antibody-associated vasculitis: update
    Cruz Santana, Alfredo Nicodemos
    Woronik, Viktoria
    Radu Halpern, Ari Stiel
    Barbas, Carmen S. V.
    JORNAL BRASILEIRO DE PNEUMOLOGIA, 2011, 37 (06) : 809 - 816
  • [38] ECULIZUMAB FOR REFRACTORY ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS
    Villagrasa, Tania
    Uriol, Miguel
    Obrador, Aina
    Allende, Natalia
    Egea, Cristina
    Montaner, Mercedes
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 : 431 - 431
  • [39] Treatment of antineutrophil cytoplasmic antibody-associated vasculitis with rituximab
    Cartin-Ceba, Rodrigo
    Fervenza, Fernando C.
    Specks, Ulrich
    CURRENT OPINION IN RHEUMATOLOGY, 2012, 24 (01) : 15 - 23
  • [40] ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS IN A XENOGENEIC MODEL
    WALKER, BAM
    SMITH, T
    KIM, SSW
    JOHNSTON, G
    FASEB JOURNAL, 1994, 8 (04): : A320 - A320